Gallagher E J, Courgi R, Heiba S, Tamler R
Division of Endocrinology, Diabetes and Bone Diseases, Department of Medicine, Mount Sinai Medical Center, New York, NY 10029, USA.
Minerva Endocrinol. 2011 Dec;36(4):341-5.
The aim of this paper was to report the case of type 2 diabetes and significant insulin resistance that improved dramatically after removal of a pheochromocytoma in a liver transplant recipient , and to provide a review of the relevant literature. We describe the clinical presentation, diagnostic results and management of the patient. In addition, we performed a PubMed search for related English language articles, to provide an overview of the pertinent literature. A 53 year old woman with a history of an orthotopic liver transplantation and insulin-requiring type 2 diabetes was admitted to the hospital with fever, diaphoresis, tachycardia and hypertension. A pheochromocytoma was diagnosed and removed. The patient subsequently developed hypoglycemia and required no further insulin therapy. Pheochromocytomas have been described to lead to hyperglycemia and diabetes, due to the suppression of insulin release and increased insulin resistance. Furthermore, a review of the literature revealed only 3 other reported cases of pheochromocytomas in organ transplant recipients. None of these pheochromocytomas were believed to have occurred de novo after transplantation. This is the first report of a pheochromocytoma in a liver transplant recipient and possibly the first case of a de novo pheochromocytoma in any organ transplant recipient. Moreover, this case showcases pheochromocytomas as a rare cause of diabetes mellitus.
本文旨在报告一例肝移植受者在切除嗜铬细胞瘤后,2型糖尿病及显著胰岛素抵抗得到显著改善的病例,并对相关文献进行综述。我们描述了该患者的临床表现、诊断结果及治疗情况。此外,我们在PubMed上搜索了相关英文文章,以提供相关文献的概述。一名有原位肝移植病史且需要胰岛素治疗的2型糖尿病53岁女性因发热、多汗、心动过速和高血压入院。诊断出嗜铬细胞瘤并将其切除。患者随后出现低血糖,无需进一步胰岛素治疗。嗜铬细胞瘤已被描述为可导致高血糖和糖尿病,原因是胰岛素释放受抑制及胰岛素抵抗增加。此外,文献综述显示,器官移植受者中仅另有3例嗜铬细胞瘤报告病例。这些嗜铬细胞瘤均不被认为是移植后新发的。这是肝移植受者中嗜铬细胞瘤的首例报告,也可能是任何器官移植受者中首例新发嗜铬细胞瘤病例。此外,该病例表明嗜铬细胞瘤是糖尿病的罕见病因。